Mesoblast Statistics
Total Valuation
Mesoblast has a market cap or net worth of 1.93 billion. The enterprise value is 2.02 billion.
| Market Cap | 1.93B |
| Enterprise Value | 2.02B |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.28B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +31.98% |
| Shares Change (QoQ) | +1.81% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 786.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 340.66 |
| PB Ratio | 4.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -19.59 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -47.39 |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.27.
| Current Ratio | 0.96 |
| Quick Ratio | 0.56 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.95 |
| Interest Coverage | -2.43 |
Financial Efficiency
Return on equity (ROE) is -21.31% and return on invested capital (ROIC) is -5.27%.
| Return on Equity (ROE) | -21.31% |
| Return on Assets (ROA) | -4.85% |
| Return on Invested Capital (ROIC) | -5.27% |
| Return on Capital Employed (ROCE) | -8.85% |
| Revenue Per Employee | 77,671 |
| Profits Per Employee | -1.42M |
| Employee Count | 73 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Mesoblast has paid 123,000 in taxes.
| Income Tax | 123,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.67% in the last 52 weeks. The beta is 1.42, so Mesoblast's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | +28.67% |
| 50-Day Moving Average | 1.32 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 44.60 |
| Average Volume (20 Days) | 147,112 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mesoblast had revenue of 5.67 million and -103.35 million in losses. Loss per share was -0.09.
| Revenue | 5.67M |
| Gross Profit | -20.99M |
| Operating Income | -51.37M |
| Pretax Income | -103.23M |
| Net Income | -103.35M |
| EBITDA | -49.43M |
| EBIT | -51.37M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 38.03 million in cash and 126.11 million in debt, giving a net cash position of -88.08 million.
| Cash & Cash Equivalents | 38.03M |
| Total Debt | 126.11M |
| Net Cash | -88.08M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 461.26M |
| Book Value Per Share | 0.40 |
| Working Capital | -3.07M |
Cash Flow
In the last 12 months, operating cash flow was -42.54 million and capital expenditures -183,000, giving a free cash flow of -42.72 million.
| Operating Cash Flow | -42.54M |
| Capital Expenditures | -183,000 |
| Free Cash Flow | -42.72M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -906.03% |
| Pretax Margin | -1,820.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Mesoblast does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.98% |
| Shareholder Yield | n/a |
| Earnings Yield | -5.35% |
| FCF Yield | -2.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Mesoblast has an Altman Z-Score of 0.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.04 |
| Piotroski F-Score | 3 |